Potential use of ivermectin for the treatment and prophylaxis of SARS-CoV-2 infection

PURPOSE OF THE STUDY: Currently no treatment has been proven to be efficacious for patients with early symptoms of COVID-19. Although most patients present mild or moderate symptoms, up to 5-10% may have a poor disease progression, so there is an urgent need for effective drugs, which can be adminis...

Descripción completa

Detalles Bibliográficos
Autores principales: Cobos-Campos, R, Apiñaniz, A, Parraza, N, Cordero, J, García, S, Orruño, E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Masson SAS. 2021
Materias:
General Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8354804/
https://www.ncbi.nlm.nih.gov/pubmed/34418758
http://dx.doi.org/10.1016/j.retram.2021.103309

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8354804/
https://www.ncbi.nlm.nih.gov/pubmed/34418758
http://dx.doi.org/10.1016/j.retram.2021.103309

Ejemplares similares